0001209191-21-004290.txt : 20210120 0001209191-21-004290.hdr.sgml : 20210120 20210120162319 ACCESSION NUMBER: 0001209191-21-004290 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210115 FILED AS OF DATE: 20210120 DATE AS OF CHANGE: 20210120 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Seibt Matthew CENTRAL INDEX KEY: 0001789088 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-33004 FILM NUMBER: 21539020 MAIL ADDRESS: STREET 1: ONE GATEWAY CENTER, SUITE 351 STREET 2: 300 WASHINGTON STREET CITY: NEWTON STATE: MA ZIP: 02458 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Acer Therapeutics Inc. CENTRAL INDEX KEY: 0001069308 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 320426967 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: ONE GATEWAY CENTER (300 WASHINGTON ST.) STREET 2: SUITE 351 CITY: NEWTON STATE: MA ZIP: 02458 BUSINESS PHONE: (844) 902-6100 MAIL ADDRESS: STREET 1: ONE GATEWAY CENTER (300 WASHINGTON ST.) STREET 2: SUITE 351 CITY: NEWTON STATE: MA ZIP: 02458 FORMER COMPANY: FORMER CONFORMED NAME: Opexa Therapeutics, Inc. DATE OF NAME CHANGE: 20060616 FORMER COMPANY: FORMER CONFORMED NAME: PharmaFrontiers Corp. DATE OF NAME CHANGE: 20051011 FORMER COMPANY: FORMER CONFORMED NAME: PHARMAFRONTIERS CORP DATE OF NAME CHANGE: 20040816 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2021-01-15 0 0001069308 Acer Therapeutics Inc. ACER 0001789088 Seibt Matthew C/O ACER THERAPEUTICS INC. ONE GATEWAY CENTER, SUITE 351 NEWTON MA 02458 0 1 0 0 Chief Commercial Officer Employee Stock Option (right to buy) 3.85 2021-01-15 4 A 0 20000 0.00 A 2031-01-15 Common Stock 20000 20000 D The option vests and becomes exercisable over four years as follows: 25% of the shares vest on January 15, 2022, and the remaining 75% of the shares vest quarterly over the remaining three years. /s/ Harry S. Palmin, Attorney-in-Fact 2021-01-19